BAYER AKTIENGESELLSCHAFT «12345...» Página 4 de 137 desde 01/07/1988 hasta 07/08/2024 01/07/2019 15:44 BAYER AKTIENGESELLSCHAFT R&D: new licenses, patents and registered trademarks Century Therapeutics launches with USD 250M financing for induced pluripotent stem cell (iPSC) allogeneic cell therapy platform Número de registro: 279759 26/06/2019 19:35 BAYER AKTIENGESELLSCHAFT Legal disputes Bayer Supervisory Board takes action to address the glyphosate litigation and welcomes the appointment of Ken Feinberg as mediator Número de registro: 279597 21/06/2019 11:26 BAYER AKTIENGESELLSCHAFT R&D: new licenses, patents and registered trademarks Not intended for U.S. and UK Media - Bayer initiates Phase III trial of Aflibercept to prevent blindness in premature infants Número de registro: 279385 19/06/2019 16:46 BAYER AKTIENGESELLSCHAFT R&D: new licenses, patents and registered trademarks Not intended for U.S. and UK Media - Regorafenib to be tested in brain cancer patients in multi-arm cooperation trial Número de registro: 279320 07/06/2019 11:48 BAYER AKTIENGESELLSCHAFT Trading: admissions, changes and removals VOLUNTARY DELISTING OF THE BAYER’S SHARES FROM THE MADRID AND BARCELONA STOCK EXCHANGES Número de registro: 278912 05/06/2019 15:12 BAYER AKTIENGESELLSCHAFT Announcements of public presentations and meetings Bayer: Invitation to Crop Science Summer Technology Showcase on August 1 - 2, 2019 Número de registro: 278884 04/06/2019 07:54 BAYER AKTIENGESELLSCHAFT R&D: new licenses, patents and registered trademarks Not intended for U.S. and UK Media - New data on larotrectinib efficacy in patients with TRK fusion cancer and primary CNS tumors or brain metastases presented at ASCO 2019 Número de registro: 278811 31/05/2019 16:15 BAYER AKTIENGESELLSCHAFT R&D: new licenses, patents and registered trademarks Not intended for U.S. and UK Media - Bayer’s darolutamide plus androgen deprivation therapy (ADT) delays worsening of disease-related symptoms and maintains quality ... Número de registro: 278762 16/05/2019 12:23 BAYER AKTIENGESELLSCHAFT R&D: new licenses, patents and registered trademarks Bayer: New data for larotrectinib at ASCO Número de registro: 278309 14/05/2019 07:17 BAYER AKTIENGESELLSCHAFT Transmissions and purchases of capital undertakings Beiersdorf to acquire iconic Coppertone™ brand from Bayer Número de registro: 278199 Página 4 de 137 «12345...»